Skip to main content
. 2023 Mar 13;4:1062892. doi: 10.3389/fpain.2023.1062892

Table 1.

Main features of the primary headaches treated with nVNS, modified from the ICHD-3, International Classification of Headache Disorders, 3rd edition.

Hemicrania continua Paroxysmal hemicrania SUNA Primary cough headache
Frequency Persistent >5 attacks/24 h >1 attack/24 h Unspecified
Chrono-biology of headache Present for >3 months At least 20 attacks
Episodic: At least two bouts lasting from 7 days to 1 year (when untreated) and separated by pain-free remission periods of >3 months
Chronic: Occurring without a remission period or with remissions lasting <3 months, for at least 1 year
Unspecified number
Episodic: At least two bouts lasting from 7 days to 1 year (when untreated) and separated by pain-free remission periods of >3 months
Chronic: Occurring without a remission period or with remissions lasting <3 months, for at least 1 year
2 attacks
Duration Constant 2–30 min 1–600 s 1 s–2 h
Description Strictly unilateral, with exacerbations of moderate or greater intensity Severe unilateral orbital supraorbital and/or temporal pain Moderate or severe unilateral head pain, with orbital, supraorbital, temporal, and/or other trigeminal distribution and occurring as single stabs, series of stabs, or in a saw-tooth pattern Sudden onset. Induced by and occurring only in association with coughing, straining, and/or Valsalva manoeuvre
Indomethacin response Responds fully to therapeutic doses of indomethacin NA NA
Cranial-autonomic symptoms At least one of the following, ipsilateral to the pain
  • (a)

    conjunctival injection/lacrimation

  • (b)

    nasal congestion and/or rhinorrhoea

  • (c)

    eyelid oedema

  • (d)

    forehead and facial sweating

  • (e)

    miosis and/or ptosis

If cranial-autonomic symptoms are absent, a sense of restlessness or agitation, or aggravation of the pain by movement is experienced.
NA
Not better accounted for by another ICHD-3

nVNS, non-invasive vagus nerve stimulation; NA, not applicable.